Allograft integration in a rabbit transgenic model for anterior cruciate ligament reconstruction - 18/03/16
Abstract |
Background |
Tissue engineering strategies include both cell-based and cell homing therapies. Ligamentous tissues are highly specialized and constitute vital components of the musculoskeletal system. Their damage causes significant morbidity and loss in function.
Hypothesis |
The aim of this study is to analyze tendinous graft integration, cell repopulation and ligamentization by using GFP+/– allografts in GFP+/– transgenic New Zealand white (NZW) rabbits.
Material and methods |
Graft implantation was designed to closely mimic anterior cruciate ligament (ACL) repair surgery. Allografts were implanted in 8 NZW rabbits and assessed at 5 days, 3 weeks and 6 weeks through: (1) arthroCT imaging, (2) morphological analysis of the transplanted allograft, (3) histological analysis, (4) collagen type I immunochemistry, and (5) GFP cell tracking. Collagen remodeling was appreciated at 3 and 6 weeks.
Results |
Graft repopulation with host cells, chondrocyte-like cells at the tendon-bone interface and graft corticalization in the bone tunnels were noticed at 3 weeks. By contrast we noticed a central necrosis aspect in the allografts intra-articularly at 6 weeks with a cell migration towards the graft edge near the synovium.
Discussion |
Our study has served to gain a better understanding of tendinous allograft bone integration, ligamentization and allograft repopulation. We believe that both cell-based therapies and cell homing therapies are beneficial in ligament tissue engineering. Future studies may elucidate whether cell repopulation occurs with pre-differentiated or progenitor cells. We believe that both cell-based therapies and cell homing therapies are beneficial in ligament tissue engineering.
Level of evidence |
Level V (animal study).
El texto completo de este artículo está disponible en PDF.Keywords : Anterior cruciate ligament, Tendinous allograft bone integration, Ligamentization, Animal study
Esquema
Vol 102 - N° 2
P. 189-195 - avril 2016 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.